Previous work from these Laboratories has established the existence of an abnormal hemoglobin in sickle cell trait and sickle cell anemia and has provided the basis for a theory relating the presence of the abnormal hemoglobin to the clinical pictures in sickle cell trait and sickle cell anemia.'
It was shown in this work that the electrophoretic picture in these conditions is compatible with the usual genetic picture that both parents of an individual suffering from sickle cell anemia have the sickle cell trait. 2 There are in the literature, however, a number of reports in which one of the parents of a sickle cell anemia victim possesses non-sickling erythrocytes. In some cases of this type the parent whose cells do not sickle has been shown to have thalassemia minor (Cooley's trait), and hematologic studies on the erythrocytes of the anemic individual have revealed the presence of properties which are present in the erythrocytes both of sickle cell disease and of thalassemia.3 4 In other cases the hemoglobin of the parent having the non-sickling cells has a greater electrophoretic mobility on the acid side of the isoelectric point than either normal hemoglobin or sickle cell hemoglobin, and the hemoglobin of the anemic child contains both this new hemoglobin and sickle cell hemoglobin.5
The present report deals with the identification of still another form of human hemoglobin in five members of a family in which the genetic picture is not typical of sickle cell anemia, although two of the members have in the past been diagnosed as having sickle cell anemia. An earlier study of this family disclosed that the two anemic children and the father, who was not anemic, had sickling erythrocytes while the mother, two sisters and two brothers of the anemic children had non-sickling erythrocytes and were not anemic. 6 The father, one brother and one sister were not available for the present study.
Experimental Methods.-(a) Sickling tests. The sodium dithionite,7 sodium metabisulfite8 and moist seal9 methods were employed. The tests were repeated on specimens which were negative for sickling.
(b) Electrophoretic studies. The methods described in previous reports from these Laboratories were employed. 1"0 The carbonmonoxyhemoglobins were studied.
(c) Solubility studies. The solubilities of the ferrohemoglobins prepared from the erythrocytes of the members of this family were determined in a series of concentrated phosphate buffers. The amorphous rather than the crystalline state was examined for reasons which will be discussed later. Similar studies were conducted on the ferrohemoglobins from normal, sickle cell trait, and sickle cell anemia individuals for control purposes. (1) Materials: Concentrated hemoglobin solutions were prepared and were dialyzed against distilled water. A potassium phosphate buffer having a total phosphate concentration of 2.8 molar and a pH of 6.8"1 was prepared from reagent grade crystalline potassium dihydrogen phosphate and dipotassium phosphate powder. (2) Experimental method: From 8.00 to 9.60 ml. of the concentrated phosphate buffer were delivered from a buret into 10-ml. volumetric flasks, and 100 mg. of sodium dithionite, Na2S204, was added to the buffer in each flask. The flasks were then filled to the 10-ml. mark with aqueous hemoglobin solution or with the hemoglobin solution and distilled water. The contents of the flasks were mixed by manual shaking, and the precipitate was separated from the solution by centrifugation. Experiments were discarded unless a visible precipitate formed within a few seconds of the mixing. The absence of a precipitate indicates either undersaturation or supersaturation, the latter occurring in some cases when the hemoglobin is present in but small excess.'2 Following the centrifugation, which caused the excess solid hemoglobin to collect above the dense solution, the solution of hemoglobin in phosphate buffer was removed. Its concentration was determined spectrophotometrically immediately after saturation with carbon monoxide. The temperature of the solutions at the end of the centrifugations was 18°4 20 C. Nomenclature.-In order to facilitate the discussion in the present paper and to avoid confusion in future works, it seems desirable at this time to establish a system of symbols for identifying the various forms of adult human hemoglobin. Table 1 lists the characteristics of the four forms of adult human hemoglobin which have been identified to date. While the names normal hemoglobin and sickle cell hemoglobin adequately describe the first two forms and will be used in this paper, names of equally descriptive nature have not yet been proposed for the two newly recognized forms. Therefore for purposes of identification and discussion normal hemoglobin, sickle cell hemoglobin,1 the abnormal hemoglobin reported by Itano found in sickle cell trait suggests two possible explanations. One explanation, that the membrane and internal structure of these cells are abnormally rigid and are able to withstand the tendency of the sickle cell hemoglobin to aggregate, is a difficult one to test unambiguously. The other explanation, that the abnormal component in these cells represents a hemoglobin which, while migrating with the same mobility as sickle cell hemoglobin, is actually a different molecular species, can be tested if an independent criterion for differentiating hemoglobins can be employed. Solubility differences exist among the hemoglobins of different species,'5 between adult and fetal hemoglobins"6 and between normal and sickle cell hemoglobins. '7' 18 The possibility that the abnormal hemoglobin in this familv might have a characteristic solubility was therefore investigated.
Although in the majority of protein solubility studies crystalline protein preparations are used, this procedure was undesirable in the present work because the process of preparing crystals is likely to cause partial fractionation of the components.'9 Other undesirable features of solubility work on crystalline proteins are the length of time required for equilibration and the danger of supersaturation.'2 The low solubility of ferrohemoglobin in comparison with other compounds of hemoglobin'6 and the large difference in the solubilities of normal and sickle cell ferrohemoglobins suggested the use of this compound throughout the solubility experiments. Another advantage of using this compound is the very small dependence of its solubility on temperature. 16 The use of sodium dithionite served a double purpose; any ferrihemoglobin which forms during the preparation of the hemoglobin solutions is reduced to ferrohemoglobin by this compound, and no oxyhemoglobin can form in the presence of an excess of sodium dithionite because of the high rate of reaction of oxygen with this reducing agent. Both ferrihemoglobin and oxyhemoglobin are considerably more soluble than ferrohemoglobin, and their temporary presence might result in supersaturation. The amount of dithionite, while sufficient to maintain the hemoglobin20 in the reduced, unoxygenated state, was small in relation to the total phosphate concentration of the buffer, so that its decomposition did not alter significantly the pH or the total ionic strength of the solutions. It was found that the equilibrium concentration of hemoglobin was attained within the time required to precipitate and separate by centrifugation the excess hemoglobin as amorphous solid. In the case of normal hemoglobin, presumably a one-component protein, the solubility of the amorphous phase was independent of the amount of the solid present. The solubility of sickle cell trait hemoglobin increased with the amount of the solid phase present, approaching a limiting value in the presence of a large excess of the two-component hemoglobin. Repeated centrifugation and resuspension of an amorphous precipitate of normal hemoglobin resulted in the formation of crystalline ferrohemo-globin, which has a lower solubility than the amorphous form. The foregoing results, plus the reproducibility of the results as indicated by figure 1, indicate that amorphous hemoglobin possesses a metastable equilibrium solubility which is characteristic of the type of hemoglobin and of the concentration of the solvent buffer, and which is greater than that of the crystalline form. These results are in accord with those obtained by other workers'6'21 on the crystalline and amorphous hemoglobins of several species.
The actual solubility in moles per liter22 of sickle cell trait hemoglobin falls much closer to that of sickle cell anemia hemoglobin than to that of normal hemoglobin although the percentage of sickle cell hemoglobin in sickle cell trait is always smaller than that of normal hemoglobin.'0 This indicates that, unlike the system treated by Northrop and Kunitz,23 the amorphous solid solution of normal and sickle cell hemoglobin does not show a Raoult's Law type of behavior in its solubility but has a solubility much lower than that predicted from Raoult's Law. This finding precludes the determination of the composition of sickle cell trait hemoglobin in its two components from solubility data alone. The deviation of the sickle cell trait solubility data from a straight line in the high solubility region is undoubtedly due to the fact that in the experiments in this region the excess of hemoglobin present was small, and the composition of the solid phase was significantly altered by the solution of a large fraction of the added hemoglobin.
The observations that the solubilities of the two-component hemoglobins of M. H. and G. H. are nearly the same as those of normal hemoglobin and five to seven times as great as that of sickle cell-trait hemoglobin, which has the same electrophoretic pattern, provide conclusive proof that the abnormal component in the hemoglobins of these individuals is not sickle cell hemoglobin. These results also suggest that, barring large interaction effects, the solubility of this abnormal hemoglobin is of the same order of magnitude as that of normal hemoglobin, which is about 14 times as soluble as sickle cell hemoglobin in the amorphous state. Thus the presence of a hitherto unreported hemoglobin component in the erythrocytes of M. H., the mother, G. H., and The genetic picture in this family appears to be analogous to the pictures presented by the families in which the sickle cell-hemoglobin c combination" and the sickle cell-thalassemia combination3 4 are present. In each of these cases an erythrocyte abnormality has been detected in the nonsickling parent of an individual having a syndrome resembling sickle cell anemia. In discussing one of these cases Neel3 has presented three possible genetic mechanisms for the transmission of the sickle cell and thalassemia characters. The decision as to the actual mechanism involved must await the accumulation of more data involving similar families and the examination of the descendants of individuals possessing the same hemoglobin constitution as R. One of the fundamental problems of genetics is the nature of differences between spontaneous and induced mutation. In higher organisms, mutations induced by ionizing radiations are known to include a relatively large number of chromosomal aberrations. Yet 
